India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...

The Lambda variant is one of 11 official SARS-CoV-2 variants recognised by the World Health Organization. It was first ...

Long COVID affects people differently from varied geographical locations. Patients in the U.S. reported much more brain fog symptoms than those in India or Nigeria.

The CDC has 1 million participants in its travel bio surveillance program, 'marking a significant milestone in the United States' ability to detect and respond to emerging public health threats.' ...

The field of molecular epidemiology has brought a transformative perspective to the study of viral infections by integrating molecular data and phylogenetic ...

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate ...

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

Key takeawaysA UCLA-led research team demonstrated that when human immune enzymes break up the spike protein of the virus ...